attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment

Solve these papers According to 3rd yr mbbs psm

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources

Quick answer

Community Medicine (PSM) Practical – Worked Solutions

Covering all 9 papers/pages you've sent (Biostatistics, Epidemiology exercises, and Case-based scenarios). Answers follow standard 3rd-year MBBS PSM practical format (Park's Textbook of PSM conventions).

PAPER 1 – Biostatistics (Boys/Girls weight; Immobility duration)

Ex 1 – Boys (n=63, mean 36.8, SD 8.6) vs Girls (n=37, mean 34.2, SD 6.5)
a) Test: Unpaired (independent samples) Student's t-test – data are quantitative (continuous weight), two independent groups, comparing two means, sample size >30 with SDs known.
b) Null hypothesis: H₀: There is no significant difference between the mean weight of boys and mean weight of girls at 10 years of age (μ₁ = μ₂); any observed difference is due to chance.
c) Calculation: SE = √(8.6²/63 + 6.5²/37) = √(1.174 + 1.142) = √2.316 = 1.522 t = (36.8−34.2)/1.522 = 2.6/1.522 = 1.71 df = 63+37−2 = 98; table t (0.05, df≈98) ≈ 1.98 Since calculated t (1.71) < table t (1.98) → not significant. Fail to reject H₀ — no statistically significant difference in mean weight between boys and girls. (matches the 1.71 already marked)
Ex 2 – Immobility days (n=10): 7,9,9,11,11,12,13,16,17,19
  • Mean = 124/10 = 12.4
  • Median = (11+12)/2 = 11.5
  • Σ(x−mean)² = 134.4 → Sample variance = 134.4/9 = 14.93 → SD ≈ 3.86 (≈3.83 as marked, minor rounding)
  • CV = (SD/Mean)×100 = 3.86/12.4×100 ≈ 31.1% (≈30.8% as marked)

PAPER 2 – Case Scenario (Avantika / Sunil-Geeta-Yash / Postnatal woman)

Case 1 – Newborn with midline spinal defect (Meningomyelocele/Spina bifida – Neural Tube Defect)
a) Supplement to prevent this: Folic acid – 400 µg (0.4 mg)/day for all women of reproductive age periconceptionally (at least 1 month before conception through first trimester); for women with a previous NTD-affected pregnancy, higher dose of 4–5 mg/day is recommended.
b) National program applicable for the child: Rashtriya Bal Swasthya Karyakram (RBSK) – screens children 0–18 years for early detection and management of birth defects/disabilities.
c) Any 4 diseases/defects covered under RBSK (4 D's):
  1. Neural tube defect / Cleft lip & palate (Defects at birth)
  2. Vitamin A/D deficiency, Severe Acute Malnutrition (Deficiencies)
  3. Rheumatic heart disease, otitis media (Diseases)
  4. Vision/hearing impairment, autism/learning delay (Development delays & Disabilities)
  • Park's PSM, p. 578 (RBSK, 4 D's – defects at birth, diseases, deficiencies, developmental delays including disability)
Case 2 – Sunil, Geeta, Yash (growth monitoring)
a) SAM diagnostic criteria (6–59 months): Any ONE of:
  • Weight-for-Height/Length < −3 SD (WHO standards), OR
  • MUAC < 11.5 cm, OR
  • Bilateral pitting oedema of nutritional origin (regardless of anthropometry)
b) Which child has SAM and why:
This is a shared conversation. Sign in to Orris to start your own chat.